BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34666752)

  • 1. Dual inhibition of α
    Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
    Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease.
    Wilkinson AL; John AE; Barrett JW; Gower E; Morrison VS; Man Y; Pun KT; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Fisher AJ; Procopiou PA; Hatley RJD; Barrett TN; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ
    Eur J Pharmacol; 2021 Dec; 913():174618. PubMed ID: 34762934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The αvβ1 integrin plays a critical in vivo role in tissue fibrosis.
    Reed NI; Jo H; Chen C; Tsujino K; Arnold TD; DeGrado WF; Sheppard D
    Sci Transl Med; 2015 May; 7(288):288ra79. PubMed ID: 25995225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis.
    Tatler AL; Goodwin AT; Gbolahan O; Saini G; Porte J; John AE; Clifford RL; Violette SM; Weinreb PH; Parfrey H; Wolters PJ; Gauldie J; Kolb M; Jenkins G
    PLoS One; 2016; 11(8):e0158047. PubMed ID: 27494713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation.
    Jolly L; Stavrou A; Vanderstoken G; Meliopoulos VA; Habgood A; Tatler AL; Porte J; Knox A; Weinreb P; Violette S; Hussell T; Kolb M; Stampfli MR; Schultz-Cherry S; Jenkins G
    J Biol Chem; 2014 Dec; 289(51):35246-63. PubMed ID: 25339175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.
    Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV
    J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis.
    John AE; Graves RH; Pun KT; Vitulli G; Forty EJ; Mercer PF; Morrell JL; Barrett JW; Rogers RF; Hafeji M; Bibby LI; Gower E; Morrison VS; Man Y; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Le J; Flint DJ; Pyne S; Habgood A; Organ LA; Joseph C; Edwards-Pritchard RC; Maher TM; Fisher AJ; Gudmann NS; Leeming DJ; Chambers RC; Lukey PT; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ
    Nat Commun; 2020 Sep; 11(1):4659. PubMed ID: 32938936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
    EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.
    John AE; Luckett JC; Tatler AL; Awais RO; Desai A; Habgood A; Ludbrook S; Blanchard AD; Perkins AC; Jenkins RG; Marshall JF
    J Nucl Med; 2013 Dec; 54(12):2146-52. PubMed ID: 24167080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 12. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
    Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
    Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
    Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts.
    Sheppard D
    Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S21-3. PubMed ID: 25830829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.
    Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z
    Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis.
    Ahangari F; Becker C; Foster DG; Chioccioli M; Nelson M; Beke K; Wang X; Justet A; Adams T; Readhead B; Meador C; Correll K; Lili LN; Roybal HM; Rose KA; Ding S; Barnthaler T; Briones N; DeIuliis G; Schupp JC; Li Q; Omote N; Aschner Y; Sharma L; Kopf KW; Magnusson B; Hicks R; Backmark A; Dela Cruz CS; Rosas I; Cousens LP; Dudley JT; Kaminski N; Downey GP
    Am J Respir Crit Care Med; 2022 Dec; 206(12):1463-1479. PubMed ID: 35998281
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrin αVβ1 regulates procollagen I production through a non-canonical transforming growth factor β signaling pathway in human hepatic stellate cells.
    Han Z; Ma Y; Cao G; Ma Z; Chen R; Cvijic ME; Cheng D
    Biochem J; 2021 May; 478(9):1689-1703. PubMed ID: 33876829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis.
    Hamanaka RB; Nigdelioglu R; Meliton AY; Tian Y; Witt LJ; O'Leary E; Sun KA; Woods PS; Wu D; Ansbro B; Ard S; Rohde JM; Dulin NO; Guzy RD; Mutlu GM
    Am J Respir Cell Mol Biol; 2018 May; 58(5):585-593. PubMed ID: 29019702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.